Alignment Healthcare, Inc. (ALHC)

In the past six months, Alignment Healthcare's stock price has been impacted by several events. CMS finalized a 2.48% net average increase in the 2027 Medicare Advantage payment rate, causing ALHC's stock to surge by 18.7%. The company reported strong financial results for the fourth quarter of 2025, with an EPS of -$0.05 and a 44.4% year-over-year revenue increase to $1.01 billion, and provided a robust outlook for 2026. However, there has also been notable insider selling, including sales by the CEO and CFO, and a secondary offering of over 13 million shares by an affiliate of General Atlantic, L.P. Despite these sales, analyst sentiment remains generally constructive, with a consensus "Moderate Buy" rating.

The demand for Alignment Healthcare's products and services, primarily Medicare Advantage plans, is highly seasonal, driven by specific enrollment periods set by Medicare. The most crucial period is the Annual Enrollment Period (AEP), which runs from October 15th to December 7th each year. Following the AEP is the Medicare Advantage Open Enrollment Period (OEP), from January 1st to March 31st, during which Medicare Advantage enrollees can make one change to their plan or switch to traditional Medicare. These periods are critical for carriers like Alignment Healthcare to compete for and secure members for the upcoming year.

Alignment Healthcare, Inc. (ALHC) is a tech-enabled healthcare company focused on delivering customized healthcare solutions primarily to seniors and individuals with chronic illnesses through its Medicare Advantage plans. The company's business model emphasizes value-based care, aiming to improve health outcomes while reducing costs. Its major products include a range of Medicare Advantage plans offering comprehensive coverage, including medical, prescription drug, dental, vision, and hearing benefits. Alignment Healthcare also provides virtual care services through its proprietary Alignment Virtual Care Center and a "Care Anywhere" program. The company leverages its data analytics platform, AVA® (Alignment Virtual Application), to enhance care delivery and member engagement.

Alignment Healthcare's geographic footprint spans across six U.S. states: Arizona, California, Florida, Nevada, North Carolina, and Texas. As of 2026, the company offers over 50 Medicare Advantage plans across 53 counties in these states, reaching approximately 8.3 million Medicare-eligible seniors.

Alignment Healthcare has maintained a strong brand reputation in the past year, particularly concerning its quality ratings. For the 2026 rating year, 100% of its Medicare Advantage members are enrolled in plans rated 4 stars or higher by CMS for the second consecutive year. The company's California HMO contract has consistently held a 4-star or higher rating for nine consecutive years, and it has two 5-star HMO contracts in Nevada, with its Nevada and North Carolina HMO contracts retaining 5-star ratings for multiple years. Furthermore, U.S. News & World Report recognized Alignment Health Plan as a Best Insurance Company for Medicare Advantage across all five states where it operates.

Institutional investors are the dominant force in Alignment Healthcare's ownership, collectively holding a substantial majority of the company's shares. As of April 10, 2026, 271 institutional owners held a total of 180,605,638 shares. Major institutional shareholders include Vanguard Group Inc., Fmr Llc, Wellington Management Group Llp, BlackRock, Inc., Invesco Ltd., T. Rowe Price Investment Management, Inc., Citadel Advisors Llc, Geode Capital Management, Llc, and Hood River Capital Management LLC. General Atlantic, a private equity firm and early investor, remains a significant shareholder. Insider ownership accounts for a notable portion of the company's stock.